DK1280526T3 - Anvendelse af 2-iminobiotin til fremstilling af et lægemiddel til forebyggelse og/eller behandling af komplikationer hos nyfödte som er opstået under födslen - Google Patents
Anvendelse af 2-iminobiotin til fremstilling af et lægemiddel til forebyggelse og/eller behandling af komplikationer hos nyfödte som er opstået under födslenInfo
- Publication number
- DK1280526T3 DK1280526T3 DK01964665T DK01964665T DK1280526T3 DK 1280526 T3 DK1280526 T3 DK 1280526T3 DK 01964665 T DK01964665 T DK 01964665T DK 01964665 T DK01964665 T DK 01964665T DK 1280526 T3 DK1280526 T3 DK 1280526T3
- Authority
- DK
- Denmark
- Prior art keywords
- iminobiotin
- treatment
- neonates
- complications
- drug
- Prior art date
Links
- WWVANQJRLPIHNS-BKPPORCPSA-N 2-iminobiotin Chemical compound N1C(=N)N[C@H]2[C@H](CCCCC(=O)O)SC[C@H]21 WWVANQJRLPIHNS-BKPPORCPSA-N 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 208000037212 Neonatal hypoxic and ischemic brain injury Diseases 0.000 abstract 2
- 102000006538 Nitric Oxide Synthase Type I Human genes 0.000 abstract 2
- 108010008858 Nitric Oxide Synthase Type I Proteins 0.000 abstract 2
- 102000011779 Nitric Oxide Synthase Type II Human genes 0.000 abstract 2
- 108010076864 Nitric Oxide Synthase Type II Proteins 0.000 abstract 2
- 102000008052 Nitric Oxide Synthase Type III Human genes 0.000 abstract 2
- 108010075520 Nitric Oxide Synthase Type III Proteins 0.000 abstract 2
- 229940124639 Selective inhibitor Drugs 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 208000033300 perinatal asphyxia Diseases 0.000 abstract 2
- 206010028923 Neonatal asphyxia Diseases 0.000 abstract 1
- 230000035606 childbirth Effects 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00201191 | 2000-03-31 | ||
| PCT/NL2001/000266 WO2001074351A1 (en) | 2000-03-31 | 2001-03-30 | Composition for the prevention and/or treatment, in newborn babies, of the effects of complications during childbirth |
| EP01964665A EP1280526B1 (de) | 2000-03-31 | 2001-03-30 | Verwendung von 2-iminobiotin zur herstellung eines arzneimittels zur prävention und / oder therapie von komplikationen bei neugeborenen, die während der geburt entstanden sind |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1280526T3 true DK1280526T3 (da) | 2005-09-05 |
Family
ID=8171295
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01964665T DK1280526T3 (da) | 2000-03-31 | 2001-03-30 | Anvendelse af 2-iminobiotin til fremstilling af et lægemiddel til forebyggelse og/eller behandling af komplikationer hos nyfödte som er opstået under födslen |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6894069B2 (de) |
| EP (1) | EP1280526B1 (de) |
| AT (1) | ATE296627T1 (de) |
| AU (1) | AU777022B2 (de) |
| CA (1) | CA2419302C (de) |
| DE (1) | DE60111214T2 (de) |
| DK (1) | DK1280526T3 (de) |
| ES (1) | ES2243542T3 (de) |
| NZ (1) | NZ524345A (de) |
| PT (1) | PT1280526E (de) |
| WO (1) | WO2001074351A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005531544A (ja) * | 2002-05-06 | 2005-10-20 | ワシントン・ユニバーシティ | Ｅｇｆｒ経路の抑制による緑内障およびｎｏｓ−２発現により媒介される他の状態の治療方法 |
| US20080176907A1 (en) * | 2006-09-19 | 2008-07-24 | Northwestern University | NOS Inhibitors For Treatment Of Motor Deficit Disorders |
| US8932842B2 (en) | 2009-02-11 | 2015-01-13 | Northwestern University | Aminopyridine dimer compounds, compositions and related methods for neuronal nitric oxide synthase inhibition |
| US8278084B2 (en) * | 2009-02-11 | 2012-10-02 | Northwestern University | Aminopyridine dimer compounds, compositions and related methods for neuronal nitric oxide synthase inhibition |
| NZ604498A (en) | 2010-05-26 | 2014-10-31 | Neurophyxia B V | 2-iminobiotin formulations and uses thereof |
| CN104735977B (zh) | 2012-06-12 | 2016-09-21 | 替代基因表达公司 | 用于在宿主细胞中表达重组蛋白的杆状病毒dna元件 |
| US10525039B2 (en) * | 2015-12-16 | 2020-01-07 | Neurophyxia B.V. | 2-iminobiotin for use in the treatment of brain cell injury |
| CN116230243B (zh) * | 2023-05-04 | 2023-07-21 | 四川大学华西医院 | 难治性癫痫伴高分流量pfo患者的封堵手术诊疗系统 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL107771A0 (en) * | 1992-11-27 | 1994-02-27 | Wellcome Found | Pharmaceutical compositions containing isothiourea derivatives certain such novel compounds and their preparation |
| US5424447A (en) | 1993-07-07 | 1995-06-13 | The Medical College Of Wisconsin Research Foundation, Inc. | Heme binding compounds and use thereof |
| US5854234A (en) | 1993-10-21 | 1998-12-29 | G. D. Searle & Co. | Amidino dervatives useful as nitric oxide synthase inhibitors |
| DE19711565A1 (de) * | 1997-02-21 | 1998-08-27 | Beiersdorf Ag | Zubereitungen für die Behandlung von Rosacea |
-
2001
- 2001-03-30 PT PT01964665T patent/PT1280526E/pt unknown
- 2001-03-30 NZ NZ524345A patent/NZ524345A/en not_active IP Right Cessation
- 2001-03-30 DK DK01964665T patent/DK1280526T3/da active
- 2001-03-30 DE DE60111214T patent/DE60111214T2/de not_active Expired - Lifetime
- 2001-03-30 WO PCT/NL2001/000266 patent/WO2001074351A1/en active IP Right Grant
- 2001-03-30 CA CA002419302A patent/CA2419302C/en not_active Expired - Fee Related
- 2001-03-30 US US10/362,051 patent/US6894069B2/en not_active Expired - Lifetime
- 2001-03-30 AT AT01964665T patent/ATE296627T1/de active
- 2001-03-30 EP EP01964665A patent/EP1280526B1/de not_active Expired - Lifetime
- 2001-03-30 ES ES01964665T patent/ES2243542T3/es not_active Expired - Lifetime
- 2001-03-30 AU AU87290/01A patent/AU777022B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US20040002530A1 (en) | 2004-01-01 |
| NZ524345A (en) | 2004-06-25 |
| PT1280526E (pt) | 2005-10-31 |
| CA2419302C (en) | 2009-12-15 |
| US6894069B2 (en) | 2005-05-17 |
| EP1280526B1 (de) | 2005-06-01 |
| AU8729001A (en) | 2001-10-15 |
| DE60111214T2 (de) | 2006-03-16 |
| WO2001074351A1 (en) | 2001-10-11 |
| AU777022B2 (en) | 2004-09-30 |
| ES2243542T3 (es) | 2005-12-01 |
| ATE296627T1 (de) | 2005-06-15 |
| CA2419302A1 (en) | 2001-10-11 |
| DE60111214D1 (de) | 2005-07-07 |
| EP1280526A1 (de) | 2003-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0708647T3 (da) | Kombination af et progestionalt middel og et nitrogenoxid-synthase-substrat og/eller -donor til behandling af præeklampsi o | |
| ATE283673T1 (de) | Intravesikaler ballon | |
| CY1111835T1 (el) | Δισκιο καθυστερημενης αποδεσμευσης με καθορισμενη γεωμετρια πυρηνα | |
| WO2002089791A3 (de) | Behandlung der akne mit lipoxygenase inhibitoren | |
| NZ330471A (en) | Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors | |
| DE50108153D1 (de) | Vorrichtung zum Beeinflussen von Zellproliferationsmechanismen in Gefässen des menschlichen oder tierischen Körpers | |
| GEP20084317B (en) | Inhibitors of human phosphatidyl-inositol 3-kinase delta | |
| DK1071417T3 (da) | Anvendelse af cannabidiol som anti-inflammatorisk middel | |
| MXPA03010085A (es) | Composiciones y su uso en la hiperplasia. | |
| DK1280526T3 (da) | Anvendelse af 2-iminobiotin til fremstilling af et lægemiddel til forebyggelse og/eller behandling af komplikationer hos nyfödte som er opstået under födslen | |
| EA200300375A1 (ru) | Производные 2-амино-2-алкил-4-гексеновой и -гексиновой кислот, которые могут быть использованы в качестве ингибиторов синтетазы оксида азота | |
| DK0755249T3 (da) | Anvendelse af Maillard-reaktionsinhibitor til behandling af amyloidose-baseret sygdom | |
| HUP0303917A2 (hu) | Szterin abszorpció inhibitor(ok) kombinációi vérmódosítókkal és ezek alkalmazása vaszkuláris kondíciók kezelésére | |
| WO2003024386A3 (en) | Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis | |
| WO2003002107A3 (en) | Use of tyrosine kinase inhibitors for treating multiple sclerosis (ms) | |
| WO2000044888A3 (en) | Dimethylarginine dimethylaminohydrolases | |
| WO2003004006A3 (en) | Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis | |
| HK1044933A1 (en) | Branched chain amino acid-dependent aminotranserase inhibitors and their use in the treatment of diabetic retinopathy. | |
| ATE423580T1 (de) | Ballonkatheter für die iliaka-gabelung | |
| BR0317539A (pt) | Métodos e composições para o tratamento de infecções por vìrus da herpes usando inibidores seletivos da ou ciclooxigenase-2 ou inibidores da ciclooxigenase-2 em combinação com agentes antivirais | |
| WO2001098365A3 (en) | Peptide and polypeptide inhibitors of complement c1s | |
| WO2000037067A3 (en) | Sensitizing agents for the treatment of skin lesions | |
| NO20012569L (no) | Anvendelse av aryl-substituerte syklobutylalkylaminer for behandling av urininkontinens | |
| AU6502194A (en) | Oestriol-containing hormonal agent for the prophylaxis and treatment of arterial conditions in humans, method of preparing it and its use | |
| PL327472A1 (en) | Nitrogen oxide (no) synthase inhibitor for use in treatment or polphylaxy of type ii diabetes |